Smart insulin system with behavior support for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had type 1 diabetes for more than one year
- You have used an FDA-approved automated insulin delivery system in the last 6 months
- You have used insulin for more than 6 months
- You have a supportive companion nearby who can help in an emergency
- You are willing to use a Dexcom continuous glucose monitor and the study's phone system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This study tests whether an automated insulin delivery system can manage blood sugar without telling it when you eat. It combines your existing pump and continuous glucose monitor with special software, and may reduce the need for carb counting.
This study tests a new automated insulin pump system (NMX8) for adults with type 1 diabetes whose blood sugar is not well controlled (HbA1c above 7.5%). You must already be using a similar pump system. The goal is to see if this new device can help you get better control.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.